1. Home
  2. RAIL vs CGEN Comparison

RAIL vs CGEN Comparison

Compare RAIL & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAIL
  • CGEN
  • Stock Information
  • Founded
  • RAIL 1901
  • CGEN 1993
  • Country
  • RAIL United States
  • CGEN Israel
  • Employees
  • RAIL N/A
  • CGEN N/A
  • Industry
  • RAIL Railroads
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RAIL Industrials
  • CGEN Health Care
  • Exchange
  • RAIL Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • RAIL 187.4M
  • CGEN 167.4M
  • IPO Year
  • RAIL N/A
  • CGEN 2000
  • Fundamental
  • Price
  • RAIL $8.24
  • CGEN $1.45
  • Analyst Decision
  • RAIL
  • CGEN
  • Analyst Count
  • RAIL 0
  • CGEN 0
  • Target Price
  • RAIL N/A
  • CGEN N/A
  • AVG Volume (30 Days)
  • RAIL 172.6K
  • CGEN 206.7K
  • Earning Date
  • RAIL 08-04-2025
  • CGEN 08-06-2025
  • Dividend Yield
  • RAIL N/A
  • CGEN N/A
  • EPS Growth
  • RAIL N/A
  • CGEN N/A
  • EPS
  • RAIL N/A
  • CGEN N/A
  • Revenue
  • RAIL $465,864,000.00
  • CGEN $22,144,000.00
  • Revenue This Year
  • RAIL $2.94
  • CGEN N/A
  • Revenue Next Year
  • RAIL $6.56
  • CGEN $159.40
  • P/E Ratio
  • RAIL N/A
  • CGEN N/A
  • Revenue Growth
  • RAIL N/A
  • CGEN N/A
  • 52 Week Low
  • RAIL $4.31
  • CGEN $1.13
  • 52 Week High
  • RAIL $16.10
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • RAIL 37.86
  • CGEN 48.38
  • Support Level
  • RAIL $8.13
  • CGEN $1.39
  • Resistance Level
  • RAIL $8.60
  • CGEN $1.46
  • Average True Range (ATR)
  • RAIL 0.36
  • CGEN 0.06
  • MACD
  • RAIL 0.01
  • CGEN 0.00
  • Stochastic Oscillator
  • RAIL 27.73
  • CGEN 52.63

About RAIL FreightCar America Inc.

FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. The company has two segments: The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and rebuilds, while the Aftermarket segment includes the selling of forged, cast and fabricated railcar parts and supplies for all railcar types, and provides aftermarket services including safety training, railcar inspections, and preventative maintenance. The company's revenue is predominantly derived from its Manufacturing segment.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: